Cite
MLA Citation
Kei Morio et al.. “Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients.” Journal of gastroenterology and hepatology, vol. 32, no. 3, 2017, pp. 645–650. http://access.bl.uk/ark:/81055/vdc_100044496532.0x00002f